Latisse
Reveal Your True Beauty at Skin Medics™ Medical Spa
The experienced professionals of Skin Medics™ Medical Spa are offering special May savings to help patients feel and look their best. From now through May 31st, 2013, save on Vitalize Peels, Latisse®, and skincare products by Lytera®.
When patients purchase 3 Vitalize Peels for $550, they will receive a FREE Lytera® Brightening System and post-procedure kit. For longer, fuller lashes, take advantage of specially priced 5mL and 3mL Latisse & TNS Essential Serum package for $419.
Patients can also receive 20% off a second Lytera® Brightening System purchase. The Lytera® system includes the SkinMedica® facial cleanser, Lytera® skin brightening complex, Tri-retinol Complex ES®, and daily defense SPF 30+.
Please note the peels must be used by December 31st, 2013 and patients must show original proof of purchase to receive the discount on a second brightening system at a later date.
To schedule an appointment, please call: 404-256-4457 ext. 232
Dermatology Associates of Atlanta Want You to Kiss Those Lines Goodbye
For a limited time, Dermatology Associates of Atlanta is offering special savings on Juvéderm® and Botox®. Now through February 28th, 2013, you can purchase one syringe of Juvéderm® and get one area of Botox® free. Patients can also save $805 when they purchase two syringes of Juvéderm® and receive two free areas of Botox®. Other available skincare specials include the purchase of Skin Medica® TNS Essential Serum® and 5mL Latisse® for a special price of $395 or the purchase of one area of Botox® for $350 to receive a free TNS Eye Repair®.
Botox® can reduce wrinkles and fine lines on the face including crow’s feet, forehead lines and frown lines. The facial filler Juvéderm® is commonly used to treat moderate to severe facial wrinkles by restoring areas of lost volume around the mouth and nose.
Be sure to take advantage of these special offers before they expire by scheduling your appointment today.
New Research Suggests Glaucoma Drug May Be Effective In Treating Male Hair Loss
As a leader in hair restoration, Dr. Edmond Griffin and his hair transplant team are committed to educating patients and others about the most advanced hair restoration techniques and treatment options. As a contributor to the advancement of hair restoration, Dr. Griffin is highly interested in hair loss research to provide his patients with the most knowledgeable advice available. 
The scientific journal, FASEB reported this fall that the FDA- approved glaucoma drug, bimatoprost, can cause hair to re-grow. Bimatoprost, also known as Latisse®, is already FDA-approved to enhance eyelashes and has shown great results for individuals with inadequate or short lashes. Now the data in the FASEB Journal article shows that this medication may be able to grow hair from the scalp as well. One of the researchers from the University of Bradford, U.K. acknowledges that further research is necessary to determine new therapeutic approaches for treating hair loss.
The researchers conducted three sets of experiments, two involving human cells and the other with mice. The human cell tests reviewed hair follicles growing in organ cultures as well as follicles taken from the scalp. The researchers found that bimatoprost led to hair growth on human organ cultures. During the mice experiment, bimatoprost was directly applied to a bald spot on the mouse and results also showed hair re-growth.
It’s important to note that this was one study’s results and additional research will be necessary to determine the effectiveness of bimatoprost for hair loss on the scalp. Traditionally, bimatoprost treatment has been reserved for the eyelashes because of the need for continual, daily application and the expense of the current drug; however, the study’s scientists are optimistic about their findings and the implications for further drug development.
If you are interested in learning more about your hair loss options, please call our office to schedule a consultation. Connect with The Griffin Center on Facebook and Twitter for the latest hair restoration news and information.
You’re Invited to Our Jane Iredale Eye Makeup Event July 2nd 2012
Dr. Edmond Griffin invites you to join the providers of Skin Medics™ Medical Spa on Monday, July 2nd 2012 at 11am to discover Jane Iredale’s eye makeup collection. The collection offers a wide variety of eye makeup that you can wear in the daytime for the office and create a more dramatic look for the evening. Long, full eyelashes and ideal eyebrow shape can take your desired daytime and evening to the next level. The eye colors are easy to blend and won’t crease. By paying a $15 deposit upon RSVP, you can enjoy an eye makeup session with a trained representative, light refreshments and virgin martinis, discounted Jane Iredale products, and a FREE Magic Mitt makeup remover. To find out more details please see the flyer below. Space is limited, so be sure to RSVP to Dermatology Associates of Atlanta at (404) 287-0368
Could Latisse be the Answer to Hair Thinning?
Latisse® is a popular treatment that is FDA approved to help users grow longer, darker, and thicker eyelashes. The treatment started off as a medicine for glaucoma when researchers noticed that their participants were also growing longer, more luxurious eyelashes during the testing process.
One doctor in Florida is now taking Latisse® from eyelash enhancer to hair restoration treatment. When one of his patients demonstrated an allergic reaction to the typical hair restoration medication Rogaine®, he suggested she use Latisse® to regrow thinning hair instead. Using a drop or two a day of Latisse® on the affected area along with a new daily vitamin regimen, the patient saw a reduction in the thinning of her hair in about four months.
However, there are definite disadvantages to using Latisse® for hair restoration including the high cost for an unproven treatment. While this one patient has benefited from the treatment, most scarring alopecias and those caused by immune problems most likely will not be improved.
Latisse® is not FDA approved for hair restoration on the scalp which means it hasn’t been tested in that area and any risks or potential long-term side effects haven’t been fully investigated. FDA approval for a new use of an already approved drug may take many years and cost millions. By the time it gets back to the patient, the price will surely be increased. For years this drug has been used in the eyes with a high degree of safety and no long term problems noted. On the skin some patients note a darkening and slight irritation when it is used on the upper eyelids.
When Latisse® is used to increase eyelash thickness and length, full results are often not seen until 16 weeks. It would not really stop the progression of hair loss for androgenetic alopecia patients, but possibly just lengthen and thicken the hairs like it does for the eyelids. Similarly, when used for eyelashes, results will gradually disappear if the treatment is stopped. The same can be assumed for the unapproved use of Latisse® as a hair restoration treatment. Once daily application is discontinued, the hair should eventually recede again leaving the user with the same thinning hair situation he or she started with.
Along the same lines, in order to maintain eyelashes grown by Latisse®, users must maintain a constant supply. While those using Latisse® for its FDA approved use for eyelashes may only need one bottle a month, those using it for hair restoration will need a much larger quantity given the size of the treatment area (3 or more of the 2-ounce bottles). With each prescription bottle of Latisse® costing an average of $100 to $150 a bottle, patients could easily spend upwards of $450 a month for as long as they want their hair restoration results to last. It seems like a high cost considering Latisse® does not promise to stop the progression of patterned baldness.
Currently FDA approved, topical and oral treatments like Rogaine®, Propecia®, and Proscar® are available to help slow and even stop hair loss; growing some hair back is also a possibility with some of these products. These products stop the progression of loss in over 80% of all patients who take/use them daily. If Latisse® does work, it would be applied in addition to the preventers of progression like Propecia®. Follicular unit hair transplant is a surgical procedure that produces permanent hair restoration results from hair loss as a result of hormones, trauma, androgenetic alopecia, and more. It’s important to remember that while off-label uses of products like Latisse® and Botox® do have potential, they also have potential for unexplored side effects until further studied.
For more information on the current list of FDA approved non-surgical and surgical hair restoration options, contact our office. We’re also on Facebook and Twitter with the latest news and update in hair restoration and research.
 |
 |
 |
Find us on Facebook, Twitter and Google+!
Newsletter
Sign Up to Receive Occasional Special Offers and Our Newsletters
* = Required Field